Dexilant not an ‘innovative drug’ under Canada's Food and Drug Regulations.Published in:Journal of Intellectual Property Law & Practice, 2013, v. 8, n. 7, p. 518, doi. 10.1093/jiplp/jpt067By:Crowne, Emir;Moazzam, LidaPublication type:Article